Ioannis Goudevenos

1.1k total citations
25 papers, 342 citations indexed

About

Ioannis Goudevenos is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Epidemiology. According to data from OpenAlex, Ioannis Goudevenos has authored 25 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Ioannis Goudevenos's work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Cardiovascular Function and Risk Factors (4 papers). Ioannis Goudevenos is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Cardiovascular Function and Risk Factors (4 papers). Ioannis Goudevenos collaborates with scholars based in Greece, United States and France. Ioannis Goudevenos's co-authors include Maria Tsoumani, Alexandros D. Tselepis, Moses Elisaf, Emmanuel S. Ganotakis, Vasilios G. Athyros, Evangelos Liberopoulos, Asterios Karagiannis, Αθανάσιος Παπαθανασίου, Dimitri P. Mikhailidis and A. Tselepis and has published in prestigious journals such as Atherosclerosis, Journal of Thrombosis and Haemostasis and Current Pharmaceutical Design.

In The Last Decade

Ioannis Goudevenos

23 papers receiving 330 citations

Peers

Ioannis Goudevenos
W. Dieter Paar Germany
Antônio Carlos Palandri Chagas Brazil
Tadao Goto Japan
Josef Coresh United States
Farbod Raiszadeh United States
Tiny Nair India
G Raneli Italy
Mar Martín‐Pérez Spain
H BLACK United States
Joep van der Leeuw Netherlands
W. Dieter Paar Germany
Ioannis Goudevenos
Citations per year, relative to Ioannis Goudevenos Ioannis Goudevenos (= 1×) peers W. Dieter Paar

Countries citing papers authored by Ioannis Goudevenos

Since Specialization
Citations

This map shows the geographic impact of Ioannis Goudevenos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ioannis Goudevenos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ioannis Goudevenos more than expected).

Fields of papers citing papers by Ioannis Goudevenos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ioannis Goudevenos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ioannis Goudevenos. The network helps show where Ioannis Goudevenos may publish in the future.

Co-authorship network of co-authors of Ioannis Goudevenos

This figure shows the co-authorship network connecting the top 25 collaborators of Ioannis Goudevenos. A scholar is included among the top collaborators of Ioannis Goudevenos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ioannis Goudevenos. Ioannis Goudevenos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iliodromitis, Konstantinos, Stylianos Tzeis, Vlasios Pyrgakis, et al.. (2023). The burden of atrial fibrillation and heart failure in hospitalized patients: A real-world survey in a nationwide snapshot. Hellenic Journal of Cardiology. 74. 18–23. 3 indexed citations
2.
Lepida, Dimitra, et al.. (2018). The contribution of left heart disease in COPD patients with pulmonary hypertension. Hellenic Journal of Cardiology. 59(3). 160–165. 8 indexed citations
3.
Tomaszuk−Kazberuk, Anna, Dimitrios Nikas, Paulina Łopatowska, et al.. (2018). Patients with Atrial Fibrillation and Chronic Kidney Disease More Often Undergo Angioplasty of Left Main Coronary Artery – a 867 Patient Study. Kidney & Blood Pressure Research. 43(6). 1796–1805. 2 indexed citations
4.
Tsiachris, Dimitris, Πέτρος Αρσένος, Polychronis Dilaveris, et al.. (2015). Post myocardial infarction risk stratification for sudden cardiac death in patients with preserved ejection fraction: PRESERVE-EF study design.. PubMed. 55(5). 361–8. 17 indexed citations
5.
Pavlides, Gregory, Antonis S. Manolis, Costas Tsioufis, et al.. (2014). Current management and quality of life of patients with acute coronary syndrome undergoing percutaneous coronary intervention in Greece: 12-Month results from antiplatelet therapy observational study II (APTOR II).. PubMed. 54(4). 255–63. 5 indexed citations
6.
Tsoumani, Maria, et al.. (2013). Clopidogrel Generic Formulations in the Era of New Antiplatelets: A Systematic Review. Current Vascular Pharmacology. 12(5). 766–777. 7 indexed citations
7.
Tsoumani, Maria, et al.. (2012). Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives. Expert Review of Clinical Pharmacology. 5(3). 319–336. 38 indexed citations
8.
Tsoumani, Maria, et al.. (2012). Platelet-Mediated Inflammation in Cardiovascular Disease. Potential Role of Platelet-Endothelium Interactions. Current Vascular Pharmacology. 10(5). 539–549. 18 indexed citations
9.
Tsoumani, Maria, et al.. (2011). Antiplatelet Efficacy of Long-Term Treatment With Clopidogrel Besylate in Patients With a History of Acute Coronary Syndrome. Angiology. 63(7). 547–551. 10 indexed citations
10.
Tsoumani, Maria, et al.. (2011). Effect of clopidogrel besylate on platelet reactivity in patients with acute coronary syndromes. Comparison with clopidogrel hydrogen sulfate. Expert Opinion on Pharmacotherapy. 13(2). 149–158. 9 indexed citations
11.
Tselepis, A., et al.. (2011). Influence of high‐density lipoprotein and paraoxonase‐1 on platelet reactivity in patients with acute coronary syndromes receiving clopidogrel therapy. Journal of Thrombosis and Haemostasis. 9(12). 2371–2378. 27 indexed citations
12.
Tselepis, Alexandros D., Manfredi Rizzo, & Ioannis Goudevenos. (2011). Therapeutic Modulation of Lipoprotein-associated Phospholipase A2 (Lp-PLA2). Current Pharmaceutical Design. 17(33). 3656–3661. 13 indexed citations
13.
Patsouras, Dimitrios, et al.. (2007). Epstein-Barr virus multi-organ attack in a twenty-year-old boy: myocarditis, pneumonia and hepatitis. Annals of Gastroenterology. 16(4).
14.
Vlahos, Antonios P., Gerald R. Marx, Doff B. McElhinney, et al.. (2007). Clinical Utility of Doppler Echocardiography in Assessing Aortic Stenosis Severity and Predicting Need for Intervention in Children. Pediatric Cardiology. 29(3). 507–514. 16 indexed citations
15.
Athyros, Vasilios G., Emmanuel S. Ganotakis, Ioannis Goudevenos, et al.. (2006). Awareness, treatment and control of the metabolic syndrome and its components: a multicentre Greek study.. PubMed. 46(6). 380–6. 47 indexed citations
16.
Athyros, Vasilios G., Emmanuel S. Ganotakis, Moses Elisaf, et al.. (2006). Prevalence of vascular disease in metabolic syndrome using three proposed definitions. International Journal of Cardiology. 117(2). 204–210. 70 indexed citations
17.
Milionis, Haralampos, et al.. (2006). Management of the elderly patient with hyperlipidaemia: recent concerns.. PubMed. 47(2). 93–9. 1 indexed citations
18.
Zervou, Eleftheria, S. P. Georgiadou, G. Liapi, et al.. (2005). Markers of hepatitis viruses and human T-lymphotropic virus types I/II in patients who have undergone open-heart surgery: Evidence of increased risk for exposure to HBV and HEV. European Journal of Internal Medicine. 16(6). 424–428. 4 indexed citations
19.
Dardas, Petros, et al.. (2000). Noninvasive indexes of left atrial diastolic function in hypertrophic cardiomyopathy. Journal of the American Society of Echocardiography. 13(9). 809–817. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W. Dieter Paar Breakdown of academic impact, for papers by Antônio Carlos Palandri Chagas Breakdown of academic impact, for papers by Tadao Goto Breakdown of academic impact, for papers by Josef Coresh Breakdown of academic impact, for papers by Farbod Raiszadeh Breakdown of academic impact, for papers by Tiny Nair Breakdown of academic impact, for papers by G Raneli Breakdown of academic impact, for papers by Mar Martín‐Pérez Breakdown of academic impact, for papers by H BLACK Breakdown of academic impact, for papers by Joep van der Leeuw
Rankless by CCL
2026